Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$823,982,143
-$217,253,666 QoQ
Shares Held
4,345,439
-17.7% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#45
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $11,745,589,806 across 15 Drug Manufacturers - General names. AZN ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,261,385 | $5,111,233,436 | |
| 2 | JNJ |
Johnson & Johnson
|
6,867,265 | $1,744,079,292 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,131,942 | $1,687,454,547 | |
| 4 | ABBV |
AbbVie Inc.
|
4,092,335 | $1,029,795,179 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
4,345,439 | $823,982,143 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,613,383 | $582,854,808 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,757,720 | $274,139,826 | |
| 8 | AMGN |
Amgen Inc
|
587,270 | $212,662,212 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $823,982,143 | 4,345,439 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,041,235,809 | 5,279,565 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||